These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38145030)

  • 1. Analyzer-to-Analyzer Variations in Assaying Ultralow Concentrated Biomarkers Associated with Neurodegenerative Diseases Using Immunomagnetic Reduction.
    Lee KH; Hsu MH; Chen HH; Yang SY
    ACS Meas Sci Au; 2023 Dec; 3(6):488-495. PubMed ID: 38145030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of Plasma Biomarkers Using Immunomagnetic Reduction: A Promising Method for the Early Diagnosis of Alzheimer's Disease.
    Yang SY; Chiu MJ; Chen TF; Horng HE
    Neurol Ther; 2017 Jul; 6(Suppl 1):37-56. PubMed ID: 28733955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a 36-Channel Instrument for Assaying Biomarkers of Ultralow Concentrations Utilizing Immunomagnetic Reduction.
    Chen HH; Hsu MH; Lee KH; Yang SY
    ACS Meas Sci Au; 2022 Oct; 2(5):485-492. PubMed ID: 36785659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of an ultra-high sensitive immunoassay with plasma biomarker for differentiating Parkinson disease dementia from Parkinson disease using antibody functionalized magnetic nanoparticles.
    Yang SY; Chiu MJ; Lin CH; Horng HE; Yang CC; Chieh JJ; Chen HH; Liu BH
    J Nanobiotechnology; 2016 Jun; 14(1):41. PubMed ID: 27278241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eight-Channel AC Magnetosusceptometer of Magnetic Nanoparticles for High-Throughput and Ultra-High-Sensitivity Immunoassay.
    Chieh JJ; Wei WC; Liao SH; Chen HH; Lee YF; Lin FC; Chiang MH; Chiu MJ; Horng HE; Yang SY
    Sensors (Basel); 2018 Mar; 18(4):. PubMed ID: 29601532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assay of Plasma Phosphorylated Tau Protein (Threonine 181) and Total Tau Protein in Early-Stage Alzheimer's Disease.
    Yang CC; Chiu MJ; Chen TF; Chang HL; Liu BH; Yang SY
    J Alzheimers Dis; 2018; 61(4):1323-1332. PubMed ID: 29376870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer's disease core biomarkers in Lewy body disorders and Alzheimer's dementia.
    Chiasserini D; Biscetti L; Eusebi P; Salvadori N; Frattini G; Simoni S; De Roeck N; Tambasco N; Stoops E; Vanderstichele H; Engelborghs S; Mollenhauer B; Calabresi P; Parnetti L
    Alzheimers Res Ther; 2017 Jul; 9(1):52. PubMed ID: 28750675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relevance of plasma biomarkers to pathologies in Alzheimer's disease, Parkinson's disease and frontotemporal dementia.
    Chiu PY; Yang FC; Chiu MJ; Lin WC; Lu CH; Yang SY
    Sci Rep; 2022 Oct; 12(1):17919. PubMed ID: 36289355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CSF total tau/α-synuclein ratio improved the diagnostic performance for Alzheimer's disease as an indicator of tau phosphorylation.
    Shim KH; Kang MJ; Suh JW; Pyun JM; Ryoo N; Park YH; Youn YC; Jang JW; Jeong JH; Park KW; Choi SH; Suk K; Lee HW; Ko PW; Lee CN; Lim TS; An SSA; Kim S;
    Alzheimers Res Ther; 2020 Jul; 12(1):83. PubMed ID: 32660565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salivary levels of disease-related biomarkers in the early stages of Parkinson's and Alzheimer's disease:
    Sabaei M; Rahimian S; Haj Mohamad Ebrahim Ketabforoush A; Rasoolijazi H; Zamani B; Hajiakhoundi F; Soleimani M; Shahidi G; Faramarzi M
    IBRO Neurosci Rep; 2023 Jun; 14():285-292. PubMed ID: 36942319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analytical and clinical performances of the automated Lumipulse cerebrospinal fluid Aβ
    Bayart JL; Hanseeuw B; Ivanoiu A; van Pesch V
    J Neurol; 2019 Sep; 266(9):2304-2311. PubMed ID: 31179518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Classifications of Neurodegenerative Disorders Using a Multiplex Blood Biomarkers-Based Machine Learning Model.
    Lin CH; Chiu SI; Chen TF; Jang JR; Chiu MJ
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32967146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma total tau predicts executive dysfunction in Parkinson's disease.
    Lin WT; Shaw JS; Cheng FY; Chen PH
    Acta Neurol Scand; 2022 Jan; 145(1):30-37. PubMed ID: 34398474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stability of Plasma Amyloid-β 1-40, Amyloid-β 1-42, and Total Tau Protein over Repeated Freeze/Thaw Cycles.
    Liu HC; Chiu MJ; Lin CH; Yang SY
    Dement Geriatr Cogn Dis Extra; 2020; 10(1):46-55. PubMed ID: 32308667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma Levels of α-Synuclein, Aβ-40 and T-tau as Biomarkers to Predict Cognitive Impairment in Parkinson's Disease.
    Chen NC; Chen HL; Li SH; Chang YH; Chen MH; Tsai NW; Yu CC; Yang SY; Lu CH; Lin WC
    Front Aging Neurosci; 2020; 12():112. PubMed ID: 32410983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The value of cerebrospinal fluid α-synuclein and the tau/α-synuclein ratio for diagnosis of neurodegenerative disorders with Lewy pathology.
    Førland MG; Tysnes OB; Aarsland D; Maple-Grødem J; Pedersen KF; Alves G; Lange J
    Eur J Neurol; 2020 Jan; 27(1):43-50. PubMed ID: 31293044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic Association between Plasma Aβ
    Chiu MJ; Yang SY; Chen TF; Lin CH; Yang FC; Chen WP; Zetterberg H; Blennow K
    ACS Chem Neurosci; 2021 Apr; 12(8):1376-1383. PubMed ID: 33825443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new tetra-plex fluorimetric assay for the quantification of cerebrospinal fluid β-amyloid42, total-tau, phospho-tau and α-synuclein in the differential diagnosis of neurodegenerative dementia.
    Diaz-Lucena D; Escaramis G; Villar-Piqué A; Hermann P; Schmitz M; Varges D; Santana I; Del Rio JA; Martí E; Ferrer I; Baldeiras I; Zerr I; Llorens F
    J Neurol; 2020 Sep; 267(9):2567-2581. PubMed ID: 32372181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood-Based ATN Biomarkers of Alzheimer's Disease: A Meta-Analysis.
    Koychev I; Jansen K; Dette A; Shi L; Holling H
    J Alzheimers Dis; 2021; 79(1):177-195. PubMed ID: 33252080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility studies for assaying alpha-fetoprotein using antibody-activated magnetic nanoparticles.
    Huang KW; Yang SY; Hong YW; Chieh JJ; Yang CC; Horng HE; Wu CC; Hong CY; Yang HC
    Int J Nanomedicine; 2012; 7():1991-6. PubMed ID: 22619536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.